iRay Technology Co Ltd
SSE:688301
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
iRay Technology Co Ltd
Free Cash Flow
iRay Technology Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
iRay Technology Co Ltd
SSE:688301
|
Free Cash Flow
-¥384.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Free Cash Flow
¥682.2m
|
CAGR 3-Years
45%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Free Cash Flow
¥1.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
24%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Free Cash Flow
¥8.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Free Cash Flow
-¥11.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Free Cash Flow
-¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
iRay Technology Co Ltd
Glance View
iRay Technology Co., Ltd., founded in China in 2011, has swiftly emerged as a pivotal player in the realm of X-ray imaging technology. Harnessing a potent blend of innovation and scientific expertise, the company specializes in developing and manufacturing advanced digital X-ray detectors. iRay's cutting-edge detectors are a core component in medical imaging systems, providing clear, high-resolution images that are crucial for accurate diagnostics. As global healthcare standards evolve, the demand for high-quality medical imaging solutions burgeons, positioning iRay as a vital contributor to the modernization of healthcare infrastructure. By capitalizing on technological advancements and the relentless pursuit of precision, iRay ensures its products meet the stringent demands of both domestic and international markets. iRay Technology's business model thrives on its ability to consistently deliver superior-quality imaging solutions while expanding its footprint across diverse sectors. Beyond healthcare, iRay's detectors find applications in industrial non-destructive testing and security inspection, diversifying its revenue streams. The company invests significantly in research and development to maintain its technological edge, aiming to drive innovations that enhance imaging performance and cost-efficiency. This investment in R&D not only fuels product enhancements but also cements iRay’s competitive advantage in a rapidly changing industry. By leveraging a robust sales and distribution network, coupled with strategic partnerships, iRay effectively capitalizes on expanding market opportunities, thereby solidifying its revenue base and ensuring sustainable growth.
See Also
What is iRay Technology Co Ltd's Free Cash Flow?
Free Cash Flow
-384.5m
CNY
Based on the financial report for Dec 31, 2025, iRay Technology Co Ltd's Free Cash Flow amounts to -384.5m CNY.
What is iRay Technology Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
1%
Over the last year, the Free Cash Flow growth was 64%. The average annual Free Cash Flow growth rates for iRay Technology Co Ltd have been 1% over the past three years .